Asiamedic Health Screening

News

Response To Query Regarding Trading Activity

BackSep 21, 2016
Announcement Title Response to Query Regarding Trading Activity
Securities ASIAMEDIC LIMITED (ASIAMED)
Date & Time of Broadcast Sep 21, 2016 17:17
Response Description ASIAMEDIC LIMITED
(the Company )
(Incorporated in the Republic of Singapore)
Company Registration No.: 197401556E

RESPONSE TO SGX ON QUERY ON UNUSUAL TRADING ACTIVITY

The board of directors ( Board ) of Asiamedic Limited (the "Company") refers to the queries from the Singapore Exchange Securities Trading Limited ( SGX-ST ) regarding trading activity on 21 September 2016. The Company sets out the SGX-ST s queries and its responses as follows:

Question 1: Are you (the issuer) aware of any information not previously announced concerning you, your subsidiaries or associated companies which, if known, might explain the trading? Such information may include events that are potentially material and price-sensitive, such as discussions and negotiations that may lead to joint ventures, mergers, acquisitions or purchase or sale of a significant asset.

Response: The Company is not aware of any information not previously announced concerning the Company and its subsidiaries (collectively the Group ), which, if known, would account for the trading.

The Company wishes to inform shareholders that the Group is continuing to actively pursue potential expansion opportunities, and take the necessary steps to boost growth and enhance shareholder value. In this regard, it continues to engage in discussions on prospective business opportunities including mergers and acquisitions. However, there is no assurance that any such discussions will result in any definitive agreement. An announcement will be made at the appropriate time if and when a definitive agreement has been reached.

In the meantime, the Company advises that shareholders exercise caution when dealing in the shares of the Company and to refrain from taking any action which may be prejudicial to their interests.

Question 2: Are you aware of any other possible explanation for the trading? Such information may include public circulation of information by rumours or reports.

Response: Save as aforesaid, the Company is not aware of any other possible explanation for the trading.

Question 3: Can you confirm your compliance with the listing rules and, in particular, Catalist Rule 703?

Response: The Company confirms that it is in compliance with the listing rules and, in particular, listing rule 703 of the Listing Manual regarding disclosure of material information.

By Order of the Board
Foo Soon Soo
Company Secretary

21 September 2016

This announcement has been prepared by the Company and its contents have been reviewed by the Company s Sponsor, Xandar Capital Pte Ltd (the Sponsor ), for compliance with the Listing Manual (Section B: Rules of Catalist) of the Singapore Exchange Securities Trading Limited (the SGX-ST ). The Sponsor has not independently verified the contents of this announcement including the accuracy or completeness of any of the information disclosed or the correctness of any of the statements made, opinions expressed or reports contained in this announcement. This announcement has not been examined or approved by the SGX-ST. The SGX-ST and the Sponsor assume no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made, or reports contained in this announcement.

The contact person for the Sponsor is Ms Pauline Sim (Registered Professional, Xandar Capital Pte Ltd) at 3 Shenton Way, #24-02 Shenton House, Singapore 068805, telephone number: (65) 63194954

Attachments

  1. Attachment 1 (Size: 368,226 bytes)